Clinical Trials Logo
  1. Home
  2. Multiple Endocrine Neoplasia
  3. NCT05812573
  4. Details
NCT05812573 Clinical Trial

A Retrospective Study for Multiple Endocrine Neoplasia

Multiple Endocrine Neoplasia Clinical Trial

Official title:
A Retrospective Study for Multiple Endocrine Neoplasia

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05812573
Other study ID # 202302051RINC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 14, 2023
Est. completion date February 14, 2024

Study information
Verified date March 2023
Source National Taiwan University Hospital
Contact Shyang-Rong Shih, MD, PhD
Phone +886-972653337
Email srshih@ntu.edu.tw
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.

Description:

The investigators will retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date February 14, 2024
Est. primary completion date April 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Patients with multiple endocrine neoplasia Exclusion Criteria: - Patients younger than 18 years old

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervention
No intervention, only observation

Locations
Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)
Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number or endocrine organs involved The number of endocrine organs involved in MEN patients 2023/2/14-2033/2/14
See also
  Status Clinical Trial Phase
Recruiting NCT03053999 - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Recruiting NCT03048266 - Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Completed NCT00501449 - Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
Terminated NCT00947167 - A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Phase 2
Completed NCT00204373 - Treatment of Zollinger-Ellison Syndrome With Prevacid Phase 4
Recruiting NCT03348501 - Study and Follow-up of Multiple Endocrine Neoplasia Type 1 N/A
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00990535 - High Dose Somatostatin Analogues in Neuroendocrine Tumors Phase 2
Completed NCT00001277 - Studies of Elevated Parathyroid Activity Phase 2
Completed NCT00001345 - Studies of Inherited Diseases of Metabolism